The Patent Office Journal 30/12/2011 
 
25514
(12) PATENT APPLICATION PUBLICATION (21) Application No.1101/MUMNP/2011 A 
(19) INDIA  
(22) Date of filing of Application :30/05/2011 (43) Publication Date : 30/12/2011 
  
(54) Title of the invention : NOVEL TRICYCLIC DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, 
PREPARATION METHOD THEREOF, AND PHARMACEUTICALS COMPOSITION CONTAINING THE SAME  
  
(51) International classification  :C07D 487/04  
(31) Priority Document No  :10-2008-0111808  
(32) Priority Date  :11/11/2008 
(33) Name of priority country  :Republic of Korea 
(86) International Application No 
        Filing Date 
:PCT/KR2009/006618
:11/11/2009 
(87) International Publication No  :WO/2010/056038  
(61) Patent of Addition to Application 
Number  
        Filing Date 
:NA 
:NA 
(62) Divisional to Application Number 
        Filing Date 
:NA 
:NA  
  
(71)Name of Applicant :  
   1)JE IL PHARMACEUTICAL CO.  LTD 
      Address of Applicant :745-5  Banpo-dong  Seocho-gu  Seoul 
137-040  Republic of Korea   
(72)Name of Inventor : 
   1)KIM  Myung-Hwa 
   2)KIM  Seung-Hyun 
   3)KU  Sae-Kwang 
   4)PARK  Chun-Ho 
   5)JOE  Bo-Young 
   6)CHUN  Kwang-Woo 
   7)YE  In-Hae 
   8)CHOI  Jong-Hee 
   9)RYU  Dong-Kyu 
   10)PARK  Ji-Seon 
   11)LEE  Han-Chang 
   12)CHOI  Ji-So 
   13)KIM  Young-Chul  
(57) Abstract : 
The present invention relates to a novel tricyclic derivative with efficient inhibitory activity against poly(ADP-ribose)polymerases 
(PARP) or pharmaceutically acceptable salts thereof, a preparation method thereof, and a pharmaceutical composition containing the 
same. The tricyclic derivative of the invention is useful for the prevention or treatment of diseases caused by excess PARP activity, 
especially neuropathic pain, neurodegenerative diseases, cardiovascular diseases, diabetic nephropathy, inflammatory diseases, 
osteoporosis, and cancer, by inhibiting the activity of poly(ADP-ribose)polymerases. 
  
 
No. of Pages : 211 No. of Claims : 13 
